Jubilant Ingrevia Ltd (BOM:543271)

Q1 2027 Jubilant Ingrevia Ltd Earnings Call Transcript

Jul 23, 2026 / 11:30 AM GMT

Release Date Price: ₹744.75 (+0.27%)

Transcript

Key Points

Positve

Jubilant Ingrevia Ltd (BOM:543271) reported a strong start to FY 2027 with a 25% year-on-year revenue growth and a 36% increase in EBITDA.
The company witnessed healthy growth in the nutrition and personal care market, driven by higher realizations for niacinamide and codeine.
The CDMO business gained momentum, with significant traction in the agro segment and a more than three-fold extension in the pipeline following roadshows in the U.S. and Europe.
The company successfully cleared over 20 customer quality and EHS audits, maintaining an exemplary safety record across its manufacturing facilities.
Jubilant Ingrevia Ltd (BOM:543271) was certified as a great place to work and ranked among the top 50 manufacturing companies for FY27.

Negative

Geopolitical uncertainties in the Middle East have affected global supply chains and price dynamics, posing challenges to the company's operations.
There was some pricing pressure in the pyridine business, although cost optimization initiatives helped sustain performance.
The company faced increased power and fuel expenses due to higher natural gas costs, impacting overall expenses.
Despite a strong start, there is uncertainty regarding the full volume visibility for the large CDMO contract due to dynamic market conditions.
The company has not upgraded its guidance of 750 to 800 crores for the year, indicating potential caution in the face of market volatility.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

JUBN.NS - Jubilant Ingrevia Ltd
Q1 2027 Jubilant Ingrevia Ltd Earnings Call
Jul 23, 2026 / 11:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to Jubilant Ingrevious Q1 FY27 Earnings Conference Call.

As a reminder, all participant clients will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes.

Should you need assistance during the call, please signal an operator by pressing then 0 on your touchstone phone.

Please note that this conference is being recorded.

I now hand the conference over to Mr. Pavlin Taneja, Head of Investor Relations at Jubilant Indivia Limited.

Thank you, and over to you, sir.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.